Table 1.
New bone rates in defects
| A | AP | AS | APS | |
|---|---|---|---|---|
| 2 weeks | ||||
| n | 8 | 8 | 8 | 8 |
| Mean (%) | 5.77 | a8.04 | b18.26 | c8.70 |
| SD (%) | 0.77 | 1.51 | 3.83 | 1.14 |
| 4 weeks | ||||
| n | 8 | 8 | 8 | 8 |
| Mean (%) | 16.58 | d23.46 | e40.11 | f38.85 |
| SD (%) | 3.76 | 4.63 | 6.26 | 6.85 |
A = AB; AP = AB+PRP; AS = AB+SDF-1α; APS = AB+PRP+SDF-1α
AB autogenous bone particles alone, PRP platelet-rich plasma, SDF-1α stromal cell-derived factor-1α
2 weeks; aversus A (p < 0.05); bversus A, AP, and APS (p < 0.001); cversus A (p < 0.05); 4 weeks; dversus A (p < 0.05); eversus A and AP (p < 0.001); fversus A and AP (p < 0.01); fversus AS (p > 0.05); p < 0.05 indicated statistical significance